250 related articles for article (PubMed ID: 3936006)
1. [Effect of ceftazidime on enterobacteria and Pseudomonas producers of beta-lactamases].
Chabbert YA; Derlot E; Courvalin P
Pathol Biol (Paris); 1985 Sep; 33(7):758-63. PubMed ID: 3936006
[TBL] [Abstract][Full Text] [Related]
2. [Activity of 9 beta-lactam antibiotics combined with clavulanic acid or sulbactam against the strains of broad-spectrum beta-lactamase (CTX-1) producing Enterobacteriaceae isolated at the Henri Mondor Hospital].
Legrand P; Soussy CJ; Orsoni A; Brickley X; Duval J
Pathol Biol (Paris); 1988 May; 36(5):425-9. PubMed ID: 3043338
[TBL] [Abstract][Full Text] [Related]
3. beta-Lactamase Id of ceftazidime-resistant Pseudomonas aeruginosa strains.
Michel-Briand Y; Nicolas T; Godard C; Plesiat P
Microbiologica; 1992 Jan; 15(1):65-9. PubMed ID: 1556960
[TBL] [Abstract][Full Text] [Related]
4. In vitro antimicrobial activity of a novel aminothiazolylglycylcephalosporin, MT0703S, compared with that of ceftazidime, cefoperazone and aztreonam.
Okamoto R; Hara T; Yoshida T; Orikasa Y; Ogino H; Iwamatsu K; Inouye S
Drugs Exp Clin Res; 1990; 16(4):157-65. PubMed ID: 2127567
[TBL] [Abstract][Full Text] [Related]
5. In vitro antibacterial activity and beta-lactamase stability of CL 118523, an aminothiazolyl iminomethoxy cephalosporin.
Chin NX; Neu HC
Chemioterapia; 1987 Oct; 6(5):329-36. PubMed ID: 3322588
[TBL] [Abstract][Full Text] [Related]
6. Cephalosporin resistance in Pseudomonas aeruginosa, with special reference to the proposed trapping of antibiotics by beta-lactamase.
Livermore DM; Williams JD; Davy KW
Chemioterapia; 1985 Feb; 4(1):28-35. PubMed ID: 3921264
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory and bactericidal activity of cefmetazole and seven other beta-lactams against different bacterial inocula.
Esposito S; Galante D; Barba D
Chemioterapia; 1986 Apr; 5(2):101-4. PubMed ID: 3518963
[TBL] [Abstract][Full Text] [Related]
8. Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests.
Jones RN; Barry AL; Thornsberry C; Gerlach EH; Fuchs PC; Gavan TL; Sommers HM
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():187-211. PubMed ID: 19802985
[TBL] [Abstract][Full Text] [Related]
9. Study of in vitro selected resistance of Pseudomonas aeruginosa to cefoperazone, ceftazidime, azthreonam and imipenem.
Van der Auwera P; Husson M; Bulliard G
Drugs Exp Clin Res; 1986; 12(11):871-83. PubMed ID: 3102194
[TBL] [Abstract][Full Text] [Related]
10. Comparative activity of ceftazidime and four other cephalosporins against gram-negative bacteria and their sensitivity to beta-lactamases.
Galante D; Esposito S; Barba D; Pennucci C; Limauro D; Scioli C
Chemioterapia; 1984 Aug; 3(4):250-4. PubMed ID: 6398123
[TBL] [Abstract][Full Text] [Related]
11. NXL104 combinations versus Enterobacteriaceae with CTX-M extended-spectrum beta-lactamases and carbapenemases.
Livermore DM; Mushtaq S; Warner M; Miossec C; Woodford N
J Antimicrob Chemother; 2008 Nov; 62(5):1053-6. PubMed ID: 18689875
[TBL] [Abstract][Full Text] [Related]
12. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
Susić E
Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
[TBL] [Abstract][Full Text] [Related]
13. Selection of beta-lactamase producers during cephalosporin and penicillin therapy.
Wiedemann B
Scand J Infect Dis Suppl; 1986; 49():100-5. PubMed ID: 3103207
[TBL] [Abstract][Full Text] [Related]
14. [Effect of multiresistance on the minimal inhibitory concentration of N-formimidoyl thienamycin and 6 comparing substances against P. aeruginosa and 4 Enterobacteriaceae species].
Schröter G; Schrettenbrunner A; Strenzel I
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Feb; 253(4):531-43. PubMed ID: 6407236
[TBL] [Abstract][Full Text] [Related]
15. [Development of Beta-lactamase resistance in enterobacteria].
Koren J; Vaculíková A
Klin Mikrobiol Infekc Lek; 2006 Jun; 12(3):103-7. PubMed ID: 17051471
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a disk approximation test of inducible beta-lactamases in Enterobacteriacae and Pseudomonas aeruginosa.
Thore M; Jalakas K; Eriksson I; Dornbusch K
APMIS; 1989 Apr; 97(4):317-24. PubMed ID: 2497754
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and antimicrobial susceptibility data for extended-spectrum beta-lactamase- and AmpC-producing Enterobacteriaceae from the MYSTIC Program in Europe and the United States (1997-2004).
Goossens H; Grabein B
Diagn Microbiol Infect Dis; 2005 Dec; 53(4):257-64. PubMed ID: 16360549
[TBL] [Abstract][Full Text] [Related]
18. Cefoxitin sensitivity as a marker for inducible beta-lactamases.
Moritz VA; Carson PB
J Med Microbiol; 1986 May; 21(3):203-7. PubMed ID: 3486293
[TBL] [Abstract][Full Text] [Related]
19. beta-Lactamase expression and outer membrane protein changes in cefpirome-resistant and ceftazidime-resistant gram-negative bacteria.
Piddock LJ; Traynor EA
J Antimicrob Chemother; 1991 Aug; 28(2):209-19. PubMed ID: 1778852
[TBL] [Abstract][Full Text] [Related]
20. Factors that influence the evolution of beta-lactam resistance in beta-lactamase-inducible strains of Enterobacter cloacae and Pseudomonas aeruginosa.
Aronoff SC; Shlaes DM
J Infect Dis; 1987 May; 155(5):936-41. PubMed ID: 3104483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
